Company intelligence / Profile preview

Sand Spring Capital

Morristown, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Sand Spring Capital is an investment management firm that operates as a hedge fund, focusing on alternative investment strategies. While the firm is not a biotechnology or pharmaceutical developer itself, it has historically engaged in investment activities across various sectors, including healthcare and life sciences. The company is primarily known for its quantitative and event-driven investment approaches rather than direct drug discovery or clinical development. Consequently, it does not maintain a therapeutic pipeline or proprietary drug modalities.

Industry: Investors

Beyond the preview

Go deeper on Sand Spring Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sand Spring Capital.

Explore the full profile